OIRA Conclusion of EO 12866 Regulatory Review


RIN: 0938-AQ41         View EO 12866 Meetings Received Date: 01/05/2016 
Title: Covered Outpatient Drugs (CMS-2345-F) 
Agency/Subagency: HHS / CMS   Stage: Final Rule 
Concluded Action: Consistent with Change  Concluded Date: 01/19/2016 
Legal Deadline: Statutory  Economically Significant: Yes 
Publication Date: 02/01/2016  Unfunded Mandates: No 
Major: Yes  Related To Homeland Security: No 
Regulatory Flexibility Analysis Required: Yes  Small Entities Affected: Businesses 
Federalism Implications: No  Affordable Care Act [Pub. L. 111-148 & 111-152]: Yes
International Impacts: No Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: Uncollected